Managing Equipment Assets Across Multiple Sites

PAMCPs

Post-Approval Change Management and the Promise of ICH Q12

Pharma's Almanac

Fed-Batch

Advancing S-Tensify™ Through Cell-Line-Specific Process Optimization

Minyong Eom; Hakyung Kim; Dongyoung Park; Sojeong Lee, Ph.D.; Daegyun Lee

Samsung Biologics

Pharma 4.0

The Business Case for Pharma 4.0: Measuring the Return on Digital Investment

David Alvaro, Ph.D.

Pharma's Almanac

Digitalization

The Digital Divide Between Drug Substance and Drug Product Manufacturing

Pharma's Almanac

Sustainability

How is sustainability shifting from a reporting exercise to a design constraint in manufacturing and development?

Pharma's Almanac

Orthogonal Methods

Orthogonal Analytics: How Much Characterization Is Enough?

David Alvaro, Ph.D.

Pharma's Almanac

Data-Driven Mfg

Data-Driven Manufacturing and Digital Twins Across the Biologics Network

Jihyeon Oh; Hongwoo Joo

Samsung Biologics

Flow Chemistry

When Flow Chemistry Solves the Manufacturing Problem

Hiroaki Yasukouchi, Ph.D.

Kaneka

AAV Analytics

Advancing AAV Gene Therapies Through Analytical Innovation

Cynthia A. Challener, Ph.D.

Pharma's Almanac

CGT Release

Release Testing as a Cell and Gene Therapy Manufacturing Bottleneck

Pharma's Almanac

Pathfinder

Solid-Phase vs. Liquid-Phase Peptide Synthesis: Which Manufacturing Strategy Is Better?

Nice Insight

Nonviral Delivery

Can Nonviral Delivery Change the Economics of Gene Therapy?

David Alvaro, Ph.D.

Pharma's Almanac